Running GAGs: myxoid matrix in tumor pathology revisited
Tóm tắt
Từ khóa
Tài liệu tham khảo
Virchow R (1858) Die cellularpathologie in ihrer Begrundung auf physiologische und pathologische Gewebelehre. Hirschwald, Berlin
Dunglison R (1865) Medical lexicon. A dictionary of medical science. Blanchard and Lea, Philadelphia
Muller J (1838) Uber den feineren bau und die formen der krankhaften geschwulste. Haberling, Berlin
Bryant T (1802) Tumors and tumor formation. Churchill, New York.
Sponsel KH, McDonald JR, Ghormley RK (1952) Myxoma and myxosarcoma of the soft tissues of the extremities. J Bone Joint Surg Am 34(A):820–826
Fletcher CDM, Unni KK, Mertens F (2002) WHO classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon
Graadt van Roggen JF, Hogendoorn PCW, Fletcher CDM (1999) Myxoid tumours of soft tissue. Histopathology 35:291–312
Steedman HF (1950) Alcian Blue 8 GS: a new stain for mucin. Q J Microsc Sci 3:477–479
Scott JE, Dorling J (1965) Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions. Histochemie 5:221–233
Kindblom LG, Angervall L (1975) Histochemical characterization of mucosubstances in bone and soft tissue-tumors. Cancer 36:985–994
Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72:455–482
Kresse H, Schonherr E (2001) Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189:266–274
Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283:21305–21309
Kadler KE, Hill A, Canty-Laird EG (2008) Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 20:495–501
White ES, Baralle FE, Muro AF (2008) New insights into form and function of fibronectin splice variants. J Pathol 216:1–14
Bosman FT, Stamenkovic I (2003) Functional structure and composition of the extracellular matrix. J Pathol 200:423–428
Lamoureux F, Baud’huin M, Duplomb L et al (2007) Proteoglycans: key partners in bone cell biology. BioEssays 29:758–771
Willems SM, Schrage YM, Baelde JJ et al (2008) Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition. Histopathology 52:465–474
Rodgers KD, San Antonio JD, Jacenko O (2008) Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators. Dev Dyn 237:2622–2642
Evanko SP, Angello JC, Wight TN (1999) Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:1004–1013
Zimmermann DR, Dours-Zimmermann MT, Schubert M et al (1994) Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol 124:817–825
McEwan PA, Scott PG, Bishop PN et al (2006) Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 155:294–305
Geng Y, McQuillan D, Roughley PJ (2006) SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol 25:484–491
Ferdous Z, Wei VM, Iozzo R et al (2007) Decorin-transforming growth factor- interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J Biol Chem 282:35887–35898
Danielson KG, Baribault H, Holmes DF et al (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729–743
Martinez DA, Vailas AC, Vanderby R et al (2007) Temporal extracellular matrix adaptations in ligament during wound healing and hindlimb unloading. Am J Physiol Regul Integr Comp Physiol 293:R1552–R1560
Sullivan LH (1896) The tall office building artistically considered. Lippincott’s Magazine 57:403–409
Ehnis T, Dieterich W, Bauer M et al (1997) Localization of a binding site for the proteoglycan decorin on collagen XIV (undulin). J Biol Chem 272:20414–20419
Ehnis T, Dieterich W, Bauer M et al (1996) A chondroitin/dermatan sulfate form of CD44 is a receptor for collagen XIV (undulin). Exp Cell Res 229:388–397
Canty EG, Kadler KE (2005) Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118:1341–1353
Willems SM, Mohseny AB, Balog C et al (2009) Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. J Cell Mol Med 7:1291–1301
Ruehl M, Erben U, Schuppan D et al (2005) The elongated first fibronectin type III domain of collagen XIV is an inducer of quiescence and differentiation in fibroblasts and preadipocytes. J Biol Chem 280:38537–38543
Vakonakis I, Campbell ID (2007) Extracellular matrix: from atomic resolution to ultrastructure. Curr Opin Cell Biol 19:578–583
Larsen M, Artym VV, Green JA et al (2006) The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 18:463–471
Harty M, Neff AW, King MW et al (2003) Regeneration or scarring: an immunologic perspective. Dev Dyn 226:268–279
Jones FS, Jones PL (2000) The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 218:235–259
Fletcher CDM (1990) Benign fibrous histiocytoma of subcutaneous and deep soft tissue: a clinicopathologic analysis of 21 cases. Am J Surg Pathol 14:801–809
Carney JA, Gordon H, Carpenter PC et al (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64:270–283
Meng GZ, Zhang HY, Zhang Z et al (2009) Myofibroblastic sarcoma vs nodular fasciitis: a comparative study of chromosomal imbalances. Am J Clin Pathol 131:701–709
Perdigao PF, Stergiopoulos SG, De Marco L et al (2005) Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas. Genes Chromosomes Cancer 44:204–211
Hallor KH, Sciot R, Staaf J et al (2009) Two genetic pathways, t(1;10) and amplification of 3p11–12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 217:716–727
Calonje E, Mentzel T, Fletcher CDM (1994) Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol 18:668–676
Willems SM, Debiec-Rychter M, Szuhai K et al (2006) Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol 19:407–416
Enzinger FM, Shiraki M (1972) Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol 3:421–435
Turc-Carel C, Limon J, Dal CP et al (1986) Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet 23:291–299
Rubin BP, Fletcher CDM (2000) Myxoid leiomyosarcoma of soft tissue, an underrecognized variant. Am J Surg Pathol 24:927–936
Brems H, Beert E, De Ravel RT et al (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10:508–515
Pedeutour F, Simon MP, Minoletti F et al (1996) Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet 72:171–174
Kaya G, Augsburger E, Chavaz P et al (2006) CD44 and hyaluronate expression in follicular mucinosis. J Cutan Pathol 33:227–230
Alves MF, Filgueira AL, Lorena DE et al (1998) Type I and type III collagens in cutaneous mucinosis. Am J Dermatopathol 20:41–47
Lengyel J, Vertes B (1956) Hyaluronic acid studies of local myxedema and of the stroma of skin cancer. Dermatologica 113:219–225
Chung IM, Gold HK, Schwartz SM et al (2002) Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 40:2072–2081
Wight TN (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14:617–623
Burke AP, Jarvelainen H, Kolodgie FD et al (2004) Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans. Mod Pathol 17:482–488
Black A, French AT, Dukes-McEwan J et al (2005) Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve. Am J Vet Res 66:1408–1414
Nasuti JF, Zhang PJ, Feldman MD et al (2004) Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg 77:532–536
Aigner T, Oliveira AM, Nascimento AG (2004) Extraskeletal myxoid chondrosarcomas do not show a chondrocytic phenotype. Mod Pathol 17:214–221
Zhao M, Lu Y, Takata T, Mock D, Nikia H et al (1999) Immunohistochemical and histochemical characterization of the mucosubstances of odontogenic myxoma: histogenesis and differential diagnosis. Pathol Res Pract 195:391–397
Zamecnik M, Michal M (2000) Low-grade fibromyxoid sarcoma: a report of eight cases with histologic, immunohistochemical, and ultrastructural study. Ann Diagn Pathol 4:207–217
Gallager RL, Helwig EB (1980) Neurothekeoma—a benign cutaneous tumor of neural origin. Am J Clin Pathol 74:759–764
Hajdu SI (1979) Pathology of soft tissue Tumors. Lea and Febiger, Philadelphia
Fukuda T, Tsuneyoshi M (2000) Adhesion proteins, cellular morphology and fibrous components around the cell/extracellular-matrix interface in myxoid liposarcomas. J Cancer Res Clin Oncol 126:320–324
Soder S, Inwards C, Muller S et al (2001) Cell biology and matrix biochemistry of chondromyxoid fibroma. Am J Clin Pathol 116:271–277
Calikoglu E, Chavaz P, Saurat JH et al (2003) Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma. Dermatology 207:104–106
Yasui W, Oda N, Ito H et al (1991) Myxoid leiomyosarcoma of the stomach: a case report. Jpn J Clin Oncol 21:447–452
Lam RM, Hawkins ET, Roszka J (1984) Cardiac myxoma: histochemical and ultrastructural localization of glycosaminoglycans and proteoglycans. Ultrastruct Pathol 6:69–81
Folpe AL, Weiss SW (2003) Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants. Am J Surg Pathol 27:421–431
Yang P, Hirose T, Hasegawa T et al (1994) Ossifying fibromyxoid tumor of soft parts: a morphological and immunohistochemical study. Pathol Int 44:448–453
Hassanein AM, Atkinson SP, Al-Quran SZ et al (2008) Acral myxoinflammatory fibroblastic sarcomas: are they all low-grade neoplasms? J Cutan Pathol 35:186–191
Johnson WC, Graham JH, Helwig EB (1965) Cutaneous myxoid cyst. A clinicopathological and histochemical study. JAMA 191:15–20
Begin LR, Clement PB, Kirk ME et al (1985) Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases. Hum Pathol 16:621–628
Calikoglu E, Augsburger E, Masouye I et al (2002) Hyaluronate accumulation and decreased CD44 expression in perifollicular solitary cutaneous myxoma. Dermatology 205:122–126
Kusafuka K, Muramatsu K, Kasami M et al (2008) Cartilaginous features in matrix-producing carcinoma of the breast: four cases report with histochemical and immunohistochemical analysis of matrix molecules. Mod Pathol 21:1282–1292
Kusafuka K, Ishiwata T, Sugisaki Y et al (2004) Lumican expression is associated with the formation of mesenchyme-like elements in salivary pleomorphic adenomas. J Pathol 203:953–960
Nara Y, Takeuchi J, Yoshida K et al (1991) Immunohistochemical characterisation of extracellular matrix components of salivary gland tumours. Br J Cancer 64:307–314
Kusafuka K, Hiraki Y, Shukunami C et al (2001) Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis. Am J Pathol 158:1465–1472
Ambros RA, Kallakury BV, Malfetano JH et al (1996) Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: correlation with prominent fibromyxoid stromal response. Int J Gynecol Pathol 15:320–325
Franchi A, Dini M, Paglierani M et al (1995) Immunolocalization of extracellular matrix components in mixed tumors of the skin. Am J Dermatopathol 17:36–41
Sabit H, Tsuneyama K, Shimonishi T et al (2001) Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma. Pathol Int 51:248–256
Giordana MT, Bertolotto A, Mauro A et al (1982) Glycosaminoglycans in human cerebral tumors. Part II. Histochemical findings and correlations. Acta Neuropathol 57:299–305
Shia J, Qin J, Erlandson RA et al (2005) Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases. Virchows Arch 447:828–834
Harrison JD, Rose PE (1985) Myxoid meningioma: histochemistry and electron microscopy. Acta Neuropathol 68:80–82
Henschen F (1926) Fall von ostitis Fibrosa mit multiplen Tumoren in deer umgebenden Muskulatur. Verh Dtsch Ges Pathol 21:93–97
Mazabraud A, Semat P, Roze R (1967) A propos de l’association de fibromyxomes des tissus mous à la dysplasie fibreuse des os. Presse Med 75:2223–2228
Angervall L, Kindblom LG, Merck C (1977) Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand A 85A:127–140
Orndal C, Mandahl N, Rydholm A et al (1990) Chromosomal evolution and tumor progression in a myxoid liposarcoma. Acta Orthop Scand 61:99–105